| Eaton Chen, MD | |
|
1 Long Wharf Dr, Suite 302, New Haven, CT 06511-5991 | |
| (203) 865-4314 | |
| (203) 776-7741 |
| Full Name | Eaton Chen |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 46 Years |
| Location | 1 Long Wharf Dr, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619991015 | NPI | - | NPPES |
| 040001310 | Other | CT | RAILROAD MEDICARE PIN |
| 001266816 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 026681 (Connecticut) | Primary |
| 207YX0602X | Otolaryngology - Otolaryngic Allergy | 026681 (Connecticut) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern New England Ear, Nose, Throat And Facial Plastic Surgery Grou | 3971655325 | 13 |
News Archive
Health care experts widely expected the Affordable Care Act to hobble Medicare Advantage, the government-funded private health plans that millions of seniors have chosen as an alternative to original Medicare.
MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance.
› Verified 4 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Health care experts widely expected the Affordable Care Act to hobble Medicare Advantage, the government-funded private health plans that millions of seniors have chosen as an alternative to original Medicare.
MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance.
› Verified 4 days ago
| Entity Name | Southern New England Ear, Nose, Throat And Facial Plastic Surgery Grou |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215164058 PECOS PAC ID: 3971655325 Enrollment ID: O20090715000326 |
News Archive
Health care experts widely expected the Affordable Care Act to hobble Medicare Advantage, the government-funded private health plans that millions of seniors have chosen as an alternative to original Medicare.
MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eaton Chen, MD 1 Long Wharf Dr, Suite 302, New Haven, CT 06511-5991 Ph: (203) 865-4314 | Eaton Chen, MD 1 Long Wharf Dr, Suite 302, New Haven, CT 06511-5991 Ph: (203) 865-4314 |
News Archive
Health care experts widely expected the Affordable Care Act to hobble Medicare Advantage, the government-funded private health plans that millions of seniors have chosen as an alternative to original Medicare.
MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance.
› Verified 4 days ago
Dr. Kiley Edward Trott, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Park Street, Wing West Pavilion Fl 2nd Floor, New Haven, CT 06504 Phone: 203-785-5430 Fax: 203-785-3970 | |
Mark S Bianchi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 55 Lock Street, New Haven, CT 06511 Phone: 203-375-0050 Fax: 203-380-1616 | |
Dr. Sara Isabel Pai, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Park St, New Haven, CT 06519 Phone: 855-476-4569 | |
Dr. Richard Peter Manes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-3970 | |
Sam D Schild, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 330 Cedar Street, New Haven, CT 06510 Phone: 203-785-5430 | |
Mark A Dagostino, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-776-1288 Fax: 203-776-7741 | |
Ken Yanagisawa, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-787-4244 Fax: 203-776-7741 |